{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:20:04Z","timestamp":1793852404129,"version":"4.6.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T00:00:00Z","timestamp":1590796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T00:00:00Z","timestamp":1590796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10067-020-05190-5","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T05:02:42Z","timestamp":1590814962000},"page":"2085-2094","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":653,"title":["Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1710-7018","authenticated-orcid":false,"given":"Mehmet","family":"Soy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7289-1816","authenticated-orcid":false,"given":"G\u00f6khan","family":"Keser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6393-7461","authenticated-orcid":false,"given":"Pamir","family":"Atag\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8632-2825","authenticated-orcid":false,"given":"Fehmi","family":"Tabak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7876-6896","authenticated-orcid":false,"given":"I\u015f\u0131k","family":"Atag\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4226-2781","authenticated-orcid":false,"given":"Servet","family":"Kayhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,30]]},"reference":[{"issue":"8","key":"5190_CR1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1001\/jama.2020.0757","volume":"323","author":"CI Paules","year":"2020","unstructured":"Paules CI, Marston HD, Fauci AS (2020) Coronavirus infections\u2014more than just the common cold. JAMA 323(8):707\u2013708","journal-title":"JAMA"},{"issue":"10223","key":"5190_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497\u2013506","journal-title":"Lancet"},{"key":"5190_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","volume":"10","author":"CB Crayne","year":"2019","unstructured":"Crayne CB, Albeituni S, Nichols KE, Cron RQ (2019) The immunology of macrophage activation syndrome. Front Immunol 10:119. https:\/\/doi.org\/10.3389\/fimmu.2019.00119 eCollection 2019","journal-title":"Front Immunol"},{"key":"5190_CR4","doi-asserted-by":"publisher","unstructured":"Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, Wang H, Shen H, Qiu L, Li Z etal (2004) Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol; 203:622\u2013630. https:\/\/doi.org\/10.1002\/path.1560","DOI":"10.1002\/path.1560"},{"issue":"2","key":"5190_CR5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.55563\/clinexprheumatol\/xcdary","volume":"38","author":"P Sarzi-Puttini","year":"2020","unstructured":"Sarzi-Puttini P, Giorgi V, Sirotti S, Marotto D, Ardizzone S, Rizzardini G, Antinori S, Galli M (2020) COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol 38(2):337\u2013342","journal-title":"Clin Exp Rheumatol"},{"key":"5190_CR6","doi-asserted-by":"publisher","unstructured":"Li X, Geng M, Peng Y, Meng L, Lu S (2020) Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. https:\/\/doi.org\/10.1016\/j.jpha.2020.03.001 Online ahead of print","DOI":"10.1016\/j.jpha.2020.03.001"},{"key":"5190_CR7","doi-asserted-by":"publisher","unstructured":"Read R (2020) Flawed methods in \u201cCOVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism\u201d. ChemRxiv Preprint. https:\/\/doi.org\/10.26434\/chemrxiv.12120912.v1","DOI":"10.26434\/chemrxiv.12120912.v1"},{"key":"5190_CR8","doi-asserted-by":"publisher","unstructured":"Wenzhong L, Hualan L (2020) COVID-19:attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism. ChemRxiv Preprint. https:\/\/doi.org\/10.26434\/chemrxiv.11938173.v8","DOI":"10.26434\/chemrxiv.11938173.v8"},{"key":"5190_CR9","doi-asserted-by":"crossref","unstructured":"Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z, Wang J, Qin Y, Zhang X, Yan X (2020) The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the experience of clinical immunologists from China. Clin Immunol:108393","DOI":"10.1016\/j.clim.2020.108393"},{"key":"5190_CR10","doi-asserted-by":"publisher","unstructured":"Zhang B, Zhou X, Zhu C, Feng F, Qiu Y, Feng J, Jia Q, Song Q, Zhu B, Wang J (2020) Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19. medRxiv. https:\/\/doi.org\/10.1101\/2020.03.12.20035048","DOI":"10.1101\/2020.03.12.20035048"},{"issue":"6","key":"5190_CR11","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/j.jinf.2020.03.025","volume":"80","author":"L Li","year":"2020","unstructured":"Li L, Chen MX (2020) Critical patients with coronavirus disease 2019: risk factors and outcome nomogram. J Inf Secur 80(6):e37\u2013e38. https:\/\/doi.org\/10.1016\/j.jinf.2020.03.025","journal-title":"J Inf Secur"},{"key":"5190_CR12","doi-asserted-by":"publisher","unstructured":"Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G, Dimopoulos MA (2020) Hematological findings and complications of COVID-19. Am J Hematol. https:\/\/doi.org\/10.1002\/ajh.25829 Online ahead of print","DOI":"10.1002\/ajh.25829"},{"issue":"1","key":"5190_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/22221751.2020.1746199","volume":"9","author":"L Lin","year":"2020","unstructured":"Lin L, Lu L, Cao W, Li T (2020) Hypothesis for potential pathogenesis of SARS-CoV-2 infection\u2014a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect 9(1):727\u2013732. https:\/\/doi.org\/10.1080\/22221751.2020.1746199","journal-title":"Emerg Microbes Infect"},{"issue":"4","key":"5190_CR14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L (2020) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8(4):420\u2013422","journal-title":"Lancet Respir Med"},{"issue":"0","key":"5190_CR15","doi-asserted-by":"publisher","first-page":"E009","DOI":"10.3760\/cma.j.cn112151-20200312-00193","volume":"49","author":"X Yao","year":"2020","unstructured":"Yao X, Li T, He Z, Ping Y, Liu H, Yu S, Mou H, Wang L, Zhang H, Fu W (2020) A pathological report of three COVID-19 cases by minimally invasive autopsies. Zhonghua bing li xue za zhi=. Chin J Pathol 49(0):E009. https:\/\/doi.org\/10.3760\/cma.j.cn112151-20200312-00193","journal-title":"Chin J Pathol"},{"key":"5190_CR16","doi-asserted-by":"publisher","unstructured":"Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, Chen H, Ding X, Zhao H, Zhang H Covid-19 cases: coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 382(17):e38. https:\/\/doi.org\/10.1056\/NEJMc2007575","DOI":"10.1056\/NEJMc2007575"},{"key":"5190_CR17","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3389\/fimmu.2019.01745","volume":"10","author":"O Schnappauf","year":"2019","unstructured":"Schnappauf O, Chae JJ, Kastner DL, Aksentijevich I (2019) The Pyrin inflammasome in health and disease. Front Immunol 10:1745","journal-title":"Front Immunol"},{"issue":"Suppl 1","key":"5190_CR18","first-page":"3","volume":"36","author":"OM Lucherini","year":"2018","unstructured":"Lucherini OM, Rigante D, Sota J, Fabiani C, Obici L, Cattalini M, Gattorno M, Cantarini L (2018) Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases. Clin Exp Rheumatol 36(Suppl 1):3\u20139","journal-title":"Clin Exp Rheumatol"},{"key":"5190_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-med-052814-023338","volume":"67","author":"FJ Barrat","year":"2016","unstructured":"Barrat FJ, Elkon KB, Fitzgerald KA (2016) Importance of nucleic acid recognition in inflammation and autoimmunity. Annu Rev Med 67:323\u2013336","journal-title":"Annu Rev Med"},{"issue":"24","key":"5190_CR20","doi-asserted-by":"publisher","first-page":"12330","DOI":"10.1128\/JVI.01470-15","volume":"89","author":"ZB Zalinger","year":"2015","unstructured":"Zalinger ZB, Elliott R, Rose KM, Weiss SR (2015) MDA5 is critical to host defense during infection with murine coronavirus. J Virol 89(24):12330\u201312340","journal-title":"J Virol"},{"issue":"1","key":"5190_CR21","doi-asserted-by":"publisher","first-page":"e000336","DOI":"10.1136\/lupus-2019-000336","volume":"6","author":"MK Crow","year":"2019","unstructured":"Crow MK, Ronnblom L (2019) Type I interferons in host defence and inflammatory diseases. Lupus Sci Med 6(1):e000336","journal-title":"Lupus Sci Med"},{"key":"5190_CR22","doi-asserted-by":"publisher","unstructured":"Al-Samkari H, Berliner N (2018) Hemophagocytic lymphohistiocytosis. Annual review of pathology: mechanisms of disease. 13:27\u201349. https:\/\/doi.org\/10.1146\/annurev-pathol-020117-043625","DOI":"10.1146\/annurev-pathol-020117-043625"},{"issue":"10229","key":"5190_CR23","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033\u20131034","journal-title":"Lancet"},{"key":"5190_CR24","doi-asserted-by":"publisher","first-page":"25359","DOI":"10.1038\/srep25359","volume":"6","author":"C-K Min","year":"2016","unstructured":"Min C-K, Cheon S, Ha N-Y, Sohn KM, Kim Y, Aigerim A, Shin HM, Choi J-Y, Inn K-S, Kim J-H (2016) Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep 6:25359. https:\/\/doi.org\/10.1038\/srep25359","journal-title":"Sci Rep"},{"issue":"12","key":"5190_CR25","doi-asserted-by":"publisher","first-page":"5927","DOI":"10.1128\/JVI.02501-05","volume":"80","author":"EJ Snijder","year":"2006","unstructured":"Snijder EJ, Van Der Meer Y, Zevenhoven-Dobbe J, Onderwater JJ, van der Meulen J, Koerten HK, Mommaas AM (2006) Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J Virol 80(12):5927\u20135940","journal-title":"J Virol"},{"issue":"7","key":"5190_CR26","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1084\/jem.20161759","volume":"214","author":"IT Lamborn","year":"2017","unstructured":"Lamborn IT, Jing H, Zhang Y, Drutman SB, Abbott JK, Munir S, Bade S, Murdock HM, Santos CP, Brock LG (2017) Recurrent rhinovirus infections in a child with inherited MDA5 deficiency. J Exp Med 214(7):1949\u20131972","journal-title":"J Exp Med"},{"issue":"1","key":"5190_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.tim.2018.08.007","volume":"27","author":"AGD Junior","year":"2019","unstructured":"Junior AGD, Sampaio NG, Rehwinkel J (2019) A balancing act: MDA5 in antiviral immunity and autoinflammation. Trends Microbiol 27(1):75\u201385. https:\/\/doi.org\/10.1016\/j.tim.2018.08.007","journal-title":"Trends Microbiol"},{"issue":"3","key":"5190_CR28","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/1096-9071(200103)63:3<242::AID-JMV1007>3.0.CO;2-N","volume":"63","author":"KF To","year":"2001","unstructured":"To KF, Chan PK, Chan KF, Lee WK, Lam WY, Wong KF, Tang NL, Tsang DN, Sung RY, Buckley TA (2001) Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol 63(3):242\u2013246","journal-title":"J Med Virol"},{"issue":"2","key":"5190_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1128\/CMR.00102-14","volume":"28","author":"JF Chan","year":"2015","unstructured":"Chan JF, Lau SK, To KK, Cheng VC, Woo PC, Yuen K-Y (2015) Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev 28(2):465\u2013522","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"5190_CR30","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.4049\/jimmunol.1201719","volume":"189","author":"MJ Kaplan","year":"2012","unstructured":"Kaplan MJ, Radic M (2012) Neutrophil extracellular traps: double-edged swords of innate immunity. J Immunol 189(6):2689\u20132695","journal-title":"J Immunol"},{"key":"5190_CR31","doi-asserted-by":"crossref","unstructured":"Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, Da\u00dfler-Plenker J, Guerci P, Huynh C, Knight JS (2020) Targeting potential drivers of COVID-19: neutrophil extracellular traps. J Exp Med 217(6)","DOI":"10.1084\/jem.20200652"},{"issue":"5","key":"5190_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1152\/physiolgenomics.00033.2020","volume":"52","author":"RM Golonka","year":"2020","unstructured":"Golonka RM, Saha P, Yeoh BS, Chattopadhay S, Gewirtz AT, Joe B, Vijay-Kumar M (2020) Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease. Physiol Genomics 52(5):217\u2013221. https:\/\/doi.org\/10.1152\/physiolgenomics.00033.2020","journal-title":"Physiol Genomics"},{"key":"5190_CR33","doi-asserted-by":"publisher","unstructured":"Yang M (2020) Cell pyroptosis, a potential pathogenic mechanism of 2019-nCoV infection. SSRN: https:\/\/ssrn.com\/abstract=3527420 or https:\/\/doi.org\/10.2139\/ssrn.3527420. Accessed 26 Apr 2020","DOI":"10.2139\/ssrn.3527420"},{"issue":"2","key":"5190_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrmicro2070","volume":"7","author":"T Bergsbaken","year":"2009","unstructured":"Bergsbaken T, Fink SL, Cookson BT (2009) Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 7(2):99\u2013109","journal-title":"Nat Rev Microbiol"},{"key":"5190_CR35","doi-asserted-by":"crossref","unstructured":"Liu L, Wei Q, Lin Q, Fang J, Wang H, Kwok H, Tang H, Nishiura K, Peng J, Tan Z (2019) Anti\u2013spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI insight 4(4)","DOI":"10.1172\/jci.insight.123158"},{"key":"5190_CR36","doi-asserted-by":"publisher","first-page":"101328","DOI":"10.1016\/j.redox.2019.101328","volume":"28","author":"G Miotto","year":"2020","unstructured":"Miotto G, Rossetto M, Di Paolo ML, Orian L, Venerando R, Roveri A, Vu\u010dkovi\u0107 A-M, Travain VB, Zaccarin M, Zennaro L (2020) Insight into the mechanism of ferroptosis inhibition by ferrostatin-1. Redox Biol 28:101328","journal-title":"Redox Biol"},{"issue":"7","key":"5190_CR37","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nri2802","volume":"10","author":"BT Rouse","year":"2010","unstructured":"Rouse BT, Sehrawat S (2010) Immunity and immunopathology to viruses: what decides the outcome? Nat Rev Immunol 10(7):514\u2013526","journal-title":"Nat Rev Immunol"},{"issue":"9927","key":"5190_CR38","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","volume":"383","author":"M Ramos-Casals","year":"2014","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, L\u00f3pez-Guillermo A, Khamashta MA, Bosch X (2014) Adult haemophagocytic syndrome. Lancet 383(9927):1503\u20131516","journal-title":"Lancet"},{"issue":"5","key":"5190_CR39","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/acr.20418","volume":"63","author":"L Rossi-Semerano","year":"2011","unstructured":"Rossi-Semerano L, Hermeziu B, Fabre M, Kon\u00e9-Paut I (2011) Macrophage activation syndrome revealing familial Mediterranean fever. Arthritis Care Res 63(5):780\u2013783","journal-title":"Arthritis Care Res"},{"issue":"4","key":"5190_CR40","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S1473-3099(20)30132-8","volume":"20","author":"J Stebbing","year":"2020","unstructured":"Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, Richardson P (2020) COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis 20(4):400\u2013402","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"5190_CR41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.55563\/clinexprheumatol\/r3k9l6","volume":"38","author":"F Ferro","year":"2020","unstructured":"Ferro F, Elefante E, Baldini C, Bartoloni E, Puxeddu I, Talarico R, Mosca M, Bombardieri S (2020) COVID-19: the new challenge for rheumatologists. Clin Exp Rheumatol 38(2):175\u2013180","journal-title":"Clin Exp Rheumatol"},{"key":"5190_CR42","doi-asserted-by":"crossref","unstructured":"Day M (2020) Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. British Medical Journal Publishing Group","DOI":"10.1136\/bmj.m1086"},{"issue":"1","key":"5190_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5582\/bst.2020.01047","volume":"14","author":"J Gao","year":"2020","unstructured":"Gao J, Tian Z, Yang X (2020) Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 14(1):72\u201373. https:\/\/doi.org\/10.5582\/bst.2020.01047","journal-title":"Biosci Trends"},{"issue":"3","key":"5190_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/jir.2014.0038","volume":"35","author":"L-F Wang","year":"2015","unstructured":"Wang L-F, Lin Y-S, Huang N-C, Yu C-Y, Tsai W-L, Chen J-J, Kubota T, Matsuoka M, Chen S-R, Yang C-S (2015) Hydroxychloroquine-inhibited dengue virus is associated with host defense machinery. J Interf Cytokine Res 35(3):143\u2013156","journal-title":"J Interf Cytokine Res"},{"issue":"4","key":"5190_CR45","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/cbf.3182","volume":"34","author":"H Akpovwa","year":"2016","unstructured":"Akpovwa H (2016) Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivity. Cell Biochem Funct 34(4):191\u2013196","journal-title":"Cell Biochem Funct"},{"issue":"2","key":"5190_CR46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1473-3099(06)70361-9","volume":"6","author":"A Savarino","year":"2006","unstructured":"Savarino A, Di Trani L, Donatelli I, Cauda R, Cassone A (2006) New insights into the antiviral effects of chloroquine. Lancet Infect Dis 6(2):67\u201369","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"5190_CR47","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/cr.2012.165","volume":"23","author":"Y Yan","year":"2013","unstructured":"Yan Y, Zou Z, Sun Y, Li X, Xu K-F, Wei Y, Jin N, Jiang C (2013) Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model. Cell Res 23(2):300\u2013302","journal-title":"Cell Res"},{"issue":"1","key":"5190_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1743-422X-2-69","volume":"2","author":"MJ Vincent","year":"2005","unstructured":"Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, Seidah NG, Nichol ST (2005) Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2(1):69","journal-title":"Virol J"},{"key":"5190_CR49","doi-asserted-by":"publisher","unstructured":"Qiu T, Liang S, Dabbous M, Wang Y, Han R, Toumi M (2020) Chinese guidelines related to novel coronavirus pneumonia. Preprints:2020040207. https:\/\/doi.org\/10.20944\/preprints202004.0207.v1","DOI":"10.20944\/preprints202004.0207.v1"},{"key":"5190_CR50","doi-asserted-by":"crossref","unstructured":"Jamilloux Y, El Jammal T, Vuitton L, Gerfaud-Valentin M, Kerever S, S\u00e8ve P (2019) JAK inhibitors for the treatment of autoimmune and inflammatory diseases. Autoimmun Rev:102390","DOI":"10.1016\/j.autrev.2019.102390"},{"issue":"10223","key":"5190_CR51","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","volume":"395","author":"P Richardson","year":"2020","unstructured":"Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, Stebbing J (2020) Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet 395(10223):e30","journal-title":"Lancet"},{"key":"5190_CR52","doi-asserted-by":"publisher","unstructured":"Favalli EG, Biggioggero M, Maioli G, Caporali R (2020) Baricitinib for COVID-19: a suitable treatment? Lancet Infect Dis. https:\/\/doi.org\/10.1016\/S1473-3099(20)30262-0","DOI":"10.1016\/S1473-3099(20)30262-0"},{"issue":"1","key":"5190_CR53","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40259-018-0324-z","volume":"33","author":"BR Dholaria","year":"2019","unstructured":"Dholaria BR, Bachmeier CA, Locke F (2019) Mechanisms and management of chimeric antigen receptor T-cell therapy-related toxicities. BioDrugs 33(1):45\u201360","journal-title":"BioDrugs"},{"issue":"3","key":"5190_CR54","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2174\/157488706778250168","volume":"1","author":"C Ding","year":"2006","unstructured":"Ding C, Jones G (2006) Anti-interleukin-6 receptor antibody treatment in inflammatory autoimmune diseases. Rev Recent Clin Trials 1(3):193\u2013200","journal-title":"Rev Recent Clin Trials"},{"key":"5190_CR55","unstructured":"McIntosh K (2020) Coronavirus disease 2019 (COVID-19). Edited by Martin S Hirsch. UpToDate, https:\/\/www.uptodate com\/contents\/coronavirus-disease-2019-covid-19. Accessed 26 Apr 2020"},{"key":"5190_CR56","doi-asserted-by":"publisher","unstructured":"Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng V et al (2020) Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Clin Infect Dis:ciaa478. https:\/\/doi.org\/10.1093\/cid\/ciaa478","DOI":"10.1093\/cid\/ciaa478"},{"key":"5190_CR57","doi-asserted-by":"crossref","unstructured":"Xu X, Han M, Li T, Sun W, Wang D, Fu B, Zhou Y, Zheng X, Yang Y, Li X (2020) Effective treatment of severe COVID-19 patients with tocilizumab. http:\/\/chinaxiv.org\/abs\/202003.00026. Accesed Apr 26th, 2020","DOI":"10.1073\/pnas.2005615117"},{"issue":"3","key":"5190_CR58","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4137\/CMAMD.S4864","volume":"2010","author":"G Jones","year":"2010","unstructured":"Jones G, Ding C (2010) Tocilizumab: a review of its safety and efficacy in rheumatoid arthritis. Clin Med Insights: Arthritis Musculoskelet Dis 2010(3):81\u201389. https:\/\/doi.org\/10.4137\/CMAMD.S4864","journal-title":"Clin Med Insights: Arthritis Musculoskelet Dis"},{"issue":"1","key":"5190_CR59","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s42358-020-0117-1","volume":"60","author":"A \u015eahin","year":"2020","unstructured":"\u015eahin A, Derin ME, Albayrak F, Karaka\u015f B, Karag\u00f6z Y (2020) Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant\/unresponsive familial Mediterranean fever. Adv Rheumatol 60(1):12","journal-title":"Adv Rheumatol"},{"issue":"2","key":"5190_CR60","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","volume":"44","author":"B Shakoory","year":"2016","unstructured":"Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, Cron RQ, Opal SM (2016) Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of the macrophage activation syndrome: re-analysis of a prior phase III trial. Crit Care Med 44(2):275\u2013281","journal-title":"Crit Care Med"},{"issue":"2","key":"5190_CR61","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/14397595.2018.1457469","volume":"29","author":"\u00d6 Varan","year":"2019","unstructured":"Varan \u00d6, Kucuk H, Babaoglu H, Guven SC, Ozturk MA, Haznedaroglu S, Goker B, Tufan A (2019) Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis. Mod Rheumatol 29(2):363\u2013366","journal-title":"Mod Rheumatol"},{"issue":"1","key":"5190_CR62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/pcmedi\/pbaa002","volume":"3","author":"M Wang","year":"2020","unstructured":"Wang M, Zhou Y, Zong Z, Liang Z, Cao Y, Tang H, Song B, Huang Z, Kang Y, Feng P (2020) A precision medicine approach to managing Wuhan coronavirus pneumonia. Precision Clin Med 3(1):14\u201321. https:\/\/doi.org\/10.1093\/pcmedi\/pbaa002","journal-title":"Precision Clin Med"},{"key":"5190_CR63","doi-asserted-by":"publisher","first-page":"ofaa102","DOI":"10.1093\/ofid\/ofaa102","volume-title":"Open forum infectious diseases","author":"W Cao","year":"2020","unstructured":"Cao W, Liu X, Bai T, Fan H, Hong K, Song H, Han Y, Lin L, Ruan L, Li T (2020). High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with coronavirus disease 2019. In: Open forum infectious diseases. 7(3). ofaa102, https:\/\/doi.org\/10.1093\/ofid\/ofaa102"},{"issue":"7","key":"5190_CR64","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.3390\/ijms21072272","volume":"21","author":"S Jawhara","year":"2020","unstructured":"Jawhara S (2020) Could intravenous immunoglobulin collected from recovered coronavirus patients protect against COVID-19 and strengthen the immune system of new patients? Int J Mol Sci 21(7):2272. https:\/\/doi.org\/10.3390\/ijms21072272","journal-title":"Int J Mol Sci"},{"key":"5190_CR65","doi-asserted-by":"publisher","unstructured":"Marietta M, Ageno W, Artoni A, De Candia E, Gresele P, Marchetti M, Marcucci R, Tripodi A (2020) COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET). Blood Transfus. https:\/\/doi.org\/10.2450\/2020.0083-20","DOI":"10.2450\/2020.0083-20"},{"key":"5190_CR66","doi-asserted-by":"publisher","unstructured":"Golchin A, Seyedjafari E, Ardeshirylajimi A (2020) Mesenchymal stem cell therapy for COVID-19: present or future. Stem Cell Rev Rep:1\u20137. https:\/\/doi.org\/10.1007\/s12015-020-09973-w","DOI":"10.1007\/s12015-020-09973-w"},{"issue":"2","key":"5190_CR67","doi-asserted-by":"publisher","first-page":"216","DOI":"10.14336\/AD.2020.0228","volume":"11","author":"Z Leng","year":"2020","unstructured":"Leng Z, Zhu R, Hou W, Feng Y, Yang Y, Han Q, Shan G, Meng F, Du D, Wang S (2020) Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis 11(2):216\u2013228","journal-title":"Aging Dis"},{"issue":"2","key":"5190_CR68","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/jmv.20431","volume":"77","author":"JS Zhang","year":"2005","unstructured":"Zhang JS, Chen JT, Liu YX, Zhang ZS, Gao H, Liu Y, Wang X, Ning Y, Liu YF, Gao Q (2005) A serological survey on neutralizing antibody titer of SARS convalescent sera. J Med Virol 77(2):147\u2013150","journal-title":"J Med Virol"},{"key":"5190_CR69","doi-asserted-by":"crossref","unstructured":"de Alwis R, Chen S, Gan ES, Ooi EE (2020) Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development. EBioMedicine:102768","DOI":"10.1016\/j.ebiom.2020.102768"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05190-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05190-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05190-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T19:34:07Z","timestamp":1666726447000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05190-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,30]]},"references-count":69,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["5190"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05190-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,30]]},"assertion":[{"value":"1 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Disclosures None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"It is a review article we have no ethical approval and we declared that all procedures performed in presents study were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All of the authors accepted last version of the article and signed the author\u2019s disclosure.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All of the authors accepted last version of the article for publication and signed the author\u2019s disclosure.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}